The University of Queensland School of Public Health, Herston, Queensland, Australia.
Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Queensland, Australia.
JAMA Psychiatry. 2020 Aug 1;77(8):830-841. doi: 10.1001/jamapsychiatry.2020.1107.
The perceived helpfulness of treatment is an important patient-centered measure that is a joint function of whether treatment professionals are perceived as helpful and whether patients persist in help-seeking after previous unhelpful treatments.
To examine the prevalence and factors associated with the 2 main components of perceived helpfulness of treatment in a representative sample of individuals with a lifetime history of DSM-IV major depressive disorder (MDD).
DESIGN, SETTING, AND PARTICIPANTS: This study examined the results of a coordinated series of community epidemiologic surveys of noninstitutionalized adults using the World Health Organization World Mental Health surveys. Seventeen surveys were conducted in 16 countries (8 surveys in high-income countries and 9 in low- and middle-income countries). The dates of data collection ranged from 2002 to 2003 (Lebanon) to 2016 to 2017 (Bulgaria). Participants included those with a lifetime history of treated MDD. Data analyses were conducted from April 2019 to January 2020. Data on socioeconomic characteristics, lifetime comorbid conditions (eg, anxiety and substance use disorders), treatment type, treatment timing, and country income level were collected.
Conditional probabilities of helpful treatment after seeing between 1 and 5 professionals; persistence in help-seeking after between 1 and 4 unhelpful treatments; and ever obtaining helpful treatment regardless of number of professionals seen.
Survey response rates ranged from 50.4% (Poland) to 97.2% (Medellín, Columbia), with a pooled response rate of 68.3% (n = 117 616) across surveys. Mean (SE) age at first depression treatment was 34.8 (0.3) years, and 69.4% were female. Of 2726 people with a lifetime history of treatment of MDD, the cumulative probability (SE) of all respondents pooled across countries of helpful treatment after seeing up to 10 professionals was 93.9% (1.2%), but only 21.5% (3.2%) of patients persisted that long (ie, beyond 9 unhelpful treatments), resulting in 68.2% (1.1%) of patients ever receiving treatment that they perceived as helpful. The probability of perceiving treatment as helpful increased in association with 4 factors: older age at initiating treatment (adjusted odds ratio [AOR], 1.02; 95% CI, 1.01-1.03), higher educational level (low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), shorter delay in initiating treatment after first onset (AOR, 0.98; 95% CI, 0.97-0.99), and medication received from a mental health specialist (AOR, 2.91; 95% CI, 2.04-4.15). Decomposition analysis showed that the first 2 of these 4 factors were associated with only the conditional probability of an individual treatment professional being perceived as helpful (age at first depression treatment: AOR, 1.02; 95% CI, 1.01-1.02; educational level: low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high-average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), whereas the latter 2 factors were associated with only persistence (treatment delay: AOR, 0.98; 95% CI, 0.97-0.99; treatment type: AOR, 3.43; 95% CI, 2.51-4.70).
The probability that patients with MDD obtain treatment that they consider helpful might increase, perhaps markedly, if they persisted in help-seeking after unhelpful treatments with up to 9 prior professionals.
治疗的可感知帮助程度是一个重要的以患者为中心的指标,它是治疗专业人员是否被认为有帮助以及患者在经历先前无效治疗后是否坚持寻求帮助的共同作用。
在一个具有 DSM-IV 重性抑郁障碍(MDD)终生病史的代表性样本中,检查治疗可感知帮助程度的 2 个主要组成部分的流行率和相关因素。
设计、地点和参与者:本研究检查了使用世界卫生组织世界心理健康调查进行的一系列协调的社区流行病学调查的结果。在 16 个国家进行了 17 项调查(8 项在高收入国家,9 项在中低收入国家)。数据收集日期从 2002 年至 2003 年(黎巴嫩)到 2016 年至 2017 年(保加利亚)不等。参与者包括有 MDD 治疗史的人。数据分析于 2019 年 4 月至 2020 年 1 月进行。收集了社会经济特征、终生共病情况(例如焦虑和物质使用障碍)、治疗类型、治疗时机和国家收入水平的数据。
在看到 1 到 5 位专业人员后,治疗有帮助的条件概率;在经历 1 到 4 次无效治疗后坚持寻求帮助的概率;以及无论看到多少位专业人员,都能获得治疗帮助的概率。
调查的回复率从 50.4%(波兰)到 97.2%(哥伦比亚麦德林)不等,所有调查的汇总回复率为 68.3%(n=117616)。首次接受抑郁症治疗的平均(SE)年龄为 34.8(0.3)岁,其中 69.4%为女性。在 2726 名有 MDD 治疗史的患者中,所有国家的患者在看到多达 10 位专业人员后治疗有帮助的累积概率(SE)为 93.9%(1.2%),但只有 21.5%(3.2%)的患者坚持那么久(即,超过 9 次无效治疗),导致 68.2%(1.1%)的患者最终接受了他们认为有帮助的治疗。感知治疗有帮助的概率随着以下 4 个因素而增加:治疗开始时年龄较大(调整后的优势比[OR],1.02;95%置信区间[CI],1.01-1.03)、教育程度较高(低:OR,0.48;95%CI,0.33-0.70;低平均:OR,0.62;95%CI,0.44-0.89;高平均:OR,0.67;95%CI,0.49-0.91 与高教育程度相比)、治疗开始后延迟较短(OR,0.98;95%CI,0.97-0.99)以及从心理健康专家那里获得药物治疗(OR,2.91;95%CI,2.04-4.15)。分解分析表明,前两个因素仅与单个治疗专业人员被认为有帮助的条件概率有关(抑郁发作首次治疗的年龄:OR,1.02;95%CI,1.01-1.03;教育程度:低:OR,0.48;95%CI,0.33-0.70;低平均:OR,0.62;95%CI,0.44-0.89;高平均:OR,0.67;95%CI,0.49-0.91 与高教育程度相比),而后两个因素仅与坚持有关(治疗延迟:OR,0.98;95%CI,0.97-0.99;治疗类型:OR,3.43;95%CI,2.51-4.70)。
如果 MDD 患者在经历 9 次之前无效的治疗后坚持寻求帮助,他们获得自己认为有帮助的治疗的可能性可能会显著增加。